2. Treatment of reflux esophagitis and symptoms of Gastroesophageal reflux disease(GERD)
3. Maintenance therapy for severe reflux esophagitis and intractable peptic ulcers
4. Zollinger-Ellison syndrome
5. Antibiotics combination therapy for preventing recurrence of duodenal ulcer infected by Helicobacter pylori
6. Treatment of gastric ulcer, duodenal ulcer or erosion caused by administration of NSAID
7. Prevention of gastric, duodenal ulcer or erosion and the symptoms of dyspepsia in patients who have long term administration of NSAID with history of stomach, duodenal disease
8. Preventing recurrence of reflux esophagitis
1. Omed treat & prevent peptic ulcer, GERD and other acid-related disease efficiently and rapidly.
- Omed(omeprazole) belongs to proton pump inhibitors that block final step in gastric acid secretion and show more potent acid suppression
2. Omed is a more stable omeprazole preparation with improved bioavailability and longer duration of effect.
- Omed is the inclusion complex of omeprazole with β-cyclodextrin that has been developed by SK Biotechnology Institute
- A total of 18 countries in the world including Korea, USA, UK, Germany and France have acknowledged the omeprazole stabilizing technology of SK as a patent.
- Omed is now being exported to 8 Europe countries including Germany, UK.
310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea TEL.82-2-2008-2008
Copyright(c) 2013 SK Chemicals. All Right Reserved.